{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:47:41Z","timestamp":1793717261959,"version":"4.6.1"},"reference-count":42,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015613","name":"Lille University hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>In patients with neurofibromatosis type 1 (NF1), guidelines suggest screening for pheochromocytoma by metanephrine measurement and abdominal imaging, which may lead to the discovery of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and their differential diagnosis, gastrointestinal stromal tumors (GISTs). Other endocrine manifestations such as follicular thyroid carcinoma and primary hyperparathyroidism have also been reported in a few cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed to describe prevalence and clinical presentation of these manifestations through systematic screening in a large cohort of patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this monocentric retrospective study, 108 patients with NF1 were included and screened for endocrine manifestations and GISTs. Clinical, laboratory, molecular profile, pathology, and morphologic (abdominal computed tomography scan and\/or magnetic resonance imaging) and functional imaging were collected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-four patients (22.2% of the cohort, 16 female, mean age 42.6 years) presented with pheochromocytomas that were unilateral in 65.5%, benign in 89.7%, and with a ganglioneural component in 20.7%. Three female patients (2.8% of the cohort, aged 42-63 years) presented with well-differentiated GEP-NETs, and 4 (3.7%) with GISTs. One patient had primary hyperparathyroidism, 1 patient had medullary microcarcinoma, and 16 patients had goiter, multinodular in 10 cases. There was no correlation between pheochromocytoma and other NF1 tumoral manifestations, nor correlations between pheochromocytoma and NF1 genotype, despite a familial clustering in one-third of patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The pheochromocytoma prevalence in this NF1 cohort was higher (&amp;gt;20%) than previously described, confirming the interest of systematic screening, especially in young women. The prevalence of GEP-NETs and GISTs was about 3%, respectively. No phenotype\u2013genotype correlation was observed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvad083","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T08:15:43Z","timestamp":1686989743000},"source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1"],"prefix":"10.1210","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0052-4675","authenticated-orcid":false,"given":"Hippolyte","family":"Dupuis","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"},{"name":"University of Lille , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chevalier","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"},{"name":"University of Lille , F-59000 Lille , France"},{"name":"Department of Nuclear Medicine, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cardot-Bauters","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Jannin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"},{"name":"University of Lille , F-59000 Lille , France"},{"name":"Canther Laboratory U1277 Inserm\u2014Team \u201cMucins, Cancer and drug resistance\u201d team, Oncolille Institute , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ladsous","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cortet","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Merlen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Drouard","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Aubert","sequence":"additional","affiliation":[{"name":"Department of Pathology, Lille University Hospital , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vidaud","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine of System and Organ Diseases, Cochin Hospital, Federation of Genomic Medicine, Assistance Publique\u2014H\u00f4pitaux de Paris, AP-HP, Paris University Center , F-75014 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"},{"name":"University of Lille , F-59000 Lille , France"},{"name":"Inserm U1190, Lille University, European Genomic Institute for Diabetes , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-0463","authenticated-orcid":false,"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital , F-59000 Lille , France"},{"name":"University of Lille , F-59000 Lille , France"},{"name":"Inserm U1190, Lille University, European Genomic Institute for Diabetes , F-59000 Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"issue":"1","key":"2023070411453137900_bvad083-B1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"issue":"21","key":"2023070411453137900_bvad083-B2","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the neurofibromatosis type 1 gene product","volume":"88","author":"Gutmann","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023070411453137900_bvad083-B3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"7","key":"2023070411453137900_bvad083-B4","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"5","key":"2023070411453137900_bvad083-B5","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"issue":"5","key":"2023070411453137900_bvad083-B6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"issue":"Pt 1","key":"2023070411453137900_bvad083-B7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/brain\/awg016","article-title":"Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients","volume":"126","author":"Guillamo","year":"2003","journal-title":"Brain"},{"issue":"1","key":"2023070411453137900_bvad083-B8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","article-title":"Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966","volume":"15","author":"Bergqvist","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"1664-2392","key":"2023070411453137900_bvad083-B9","doi-asserted-by":"crossref","first-page":"678869","DOI":"10.3389\/fendo.2021.678869","article-title":"Phakomatoses and endocrine gland tumors: noteworthy and (not so) rare associations","volume":"12","author":"Chevalier","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2023070411453137900_bvad083-B10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects","volume":"303","author":"Zinnamosca","year":"2011","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"2023070411453137900_bvad083-B11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.17925\/EE.2019.15.2.95","article-title":"Clinical presentation and outcomes of phaeochromocytomas\/paragangliomas in neurofibromatosis type 1","volume":"15","author":"Al-Sharefi","year":"2019","journal-title":"Eur Endocrinol"},{"issue":"1","key":"2023070411453137900_bvad083-B12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"Gruber","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2055-8260","key":"2023070411453137900_bvad083-B13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40842-018-0065-4","article-title":"Pheochromocytoma and paraganglioma in neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening","volume":"4","author":"Petr","year":"2018","journal-title":"Clin Diabetes Endocrinol"},{"issue":"4","key":"2023070411453137900_bvad083-B14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/EJE-16-0233","article-title":"Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1","volume":"175","author":"K\u00e9p\u00e9n\u00e9kian","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2023070411453137900_bvad083-B15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/gim.2018.28","article-title":"Care of adults with neurofibromatosis type 1: a clinical practice resource of the American college of medical genetics and genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genet Med"},{"key":"2023070411453137900_bvad083-B16","author":"Neurofibromatose 1","year":"2022"},{"issue":"2090-1402","key":"2023070411453137900_bvad083-B17","first-page":"398570","article-title":"Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases","volume":"2013","author":"Salvi","year":"2013","journal-title":"Int J Surg Oncol"},{"issue":"9","key":"2023070411453137900_bvad083-B18","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.pas.0000159775.77912.15","article-title":"NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics","volume":"29","author":"Andersson","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2023070411453137900_bvad083-B19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"issue":"1873-3492","key":"2023070411453137900_bvad083-B20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2018.12.019","article-title":"Reference intervals for LC-MS\/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine","volume":"490","author":"Eisenhofer","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2023070411453137900_bvad083-B21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ejhg.2014.145","article-title":"Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?","volume":"23","author":"Pasmant","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"2023070411453137900_bvad083-B22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0029-1231025","article-title":"Treatment of malignant pheochromocytoma","volume":"41","author":"Ajall\u00e9","year":"2009","journal-title":"Horm Metab Res"},{"issue":"4","key":"2023070411453137900_bvad083-B23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/etm.2021.10613","article-title":"The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5","volume":"22","author":"Popa","year":"2021","journal-title":"Exp Ther Med"},{"issue":"10","key":"2023070411453137900_bvad083-B24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.humpath.2008.06.025","article-title":"Risk stratification of patients diagnosed with gastrointestinal stromal tumor","volume":"39","author":"Joensuu","year":"2008","journal-title":"Hum Pathol"},{"issue":"2","key":"2023070411453137900_bvad083-B25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","article-title":"Gastrointestinal stromal tumors: pathology and prognosis at different sites","volume":"23","author":"Miettinen","year":"2006","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"2023070411453137900_bvad083-B26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/neuonc\/noy013","article-title":"The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors","volume":"20","author":"Higham","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"2023070411453137900_bvad083-B27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cen.13265","article-title":"Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1","volume":"86","author":"Moramarco","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2023070411453137900_bvad083-B28","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population","volume":"79","author":"Z\u00f6ller","year":"1997","journal-title":"Cancer"},{"issue":"6","key":"2023070411453137900_bvad083-B29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00535-015-1132-6","article-title":"Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I","volume":"51","author":"Nishida","year":"2016","journal-title":"J Gastroenterol"},{"issue":"4","key":"2023070411453137900_bvad083-B30","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of pediatric vs adult pheochromocytomas and paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1178-1181","key":"2023070411453137900_bvad083-B31","first-page":"93","article-title":"Progesterone and estrogen receptors in neurofibromas of patients with NF1","volume":"1","author":"Geller","year":"2008","journal-title":"Clin Med Pathol"},{"issue":"3","key":"2023070411453137900_bvad083-B32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02915454","article-title":"Adrenal and retroperitoneal mixed neuroendocrine-neural tumors","volume":"2","author":"Kimura","year":"1991","journal-title":"Endocr Pathol"},{"issue":"2","key":"2023070411453137900_bvad083-B33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00423-021-02129-5","article-title":"Composite phaeochromocytomas-a systematic review of published literature","volume":"407","author":"Dhanasekar","year":"2022","journal-title":"Langenbecks Arch Surg"},{"issue":"10","key":"2023070411453137900_bvad083-B34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.12998\/wjcc.v5.i10.373","article-title":"Adrenal ganglioneuroma: what you need to know","volume":"5","author":"Mylonas","year":"2017","journal-title":"World J Clin Cases"},{"issue":"5","key":"2023070411453137900_bvad083-B35","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen's disease and pheochromocytomas","volume":"162","author":"Walther","year":"1999","journal-title":"J Urol"},{"issue":"4","key":"2023070411453137900_bvad083-B36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","article-title":"Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d\u2019Etude de la Maladie de von Hippel-Lindau","volume":"119","author":"Hammel","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"2023070411453137900_bvad083-B37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/jc.2018-01170","article-title":"UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1676 patients from the French population","volume":"104","author":"Romanet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1687-8337","key":"2023070411453137900_bvad083-B38","first-page":"8401518","article-title":"Factors associated with the prevalence of thyroid nodules and goiter in middle-aged euthyroid subjects","volume":"2017","author":"Dauksiene","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2023070411453137900_bvad083-B39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4274\/jcrpe.galenos.2020.2020.0051","article-title":"Vandetanib in a child affected by neurofibromatosis type 1 and medullary thyroid carcinoma with both NF1 and homozygous RET proto-oncogen germ-line mutations","volume":"13","author":"Demir G\u00fcndo\u011fan","year":"2021","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"2052-0573","key":"2023070411453137900_bvad083-B40","first-page":"18-0006","article-title":"Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1","volume":"2018","author":"Wong","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"6","key":"2023070411453137900_bvad083-B41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","article-title":"Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis","volume":"5","author":"Laycock-van Spyk","year":"2011","journal-title":"Hum Genomics"},{"issue":"11","key":"2023070411453137900_bvad083-B42","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 Molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvad083\/50633064\/bvad083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/7\/8\/bvad083\/50794929\/bvad083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/7\/8\/bvad083\/50794929\/bvad083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T13:21:05Z","timestamp":1688476865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvad083\/7199844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvad083","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,6,17]]},"article-number":"bvad083"}}